Instrument Inactif

Communiqués Pronova BioPharma ASA

Actions

PRON

NO0010382021

Recherche biotechnologique et médicale

Communiqués

02/03/20	Pronova BioPharma : Probe Metals to Acquire 100% Interest in the Monique Property, Val-d’Or East Project, Quebec	PU
10/12/19	Pronova BioPharma : Probe Metals Completes $17 Million Bought Deal Private Placement	PU
13/11/19	Pronova BioPharma : Probe Metals Upsizes Bought Deal Private Placement to $17.0 Million	PU
11/11/19	Pronova BioPharma : Probe Metals Announces a $10 Million Bought Deal Private Placement of Flow-Through Units	PU
21/11/12	Pronova BioPharma ASA : Notification of large trade/mandatory notification of trade	PU
28/09/12	Pronova BioPharma AS : New Drug Application Approval for Lotriga® 2g in Japan	PU
30/05/12	Pronova BioPharma AS : Pronova BioPharma ASA: US District Court rules in Pronova BioPharma's favour on Lovaza(TM) patents	PU
11/05/12	Pronova BioPharma AS : Pronova BioPharma ASA: Strong Progress Towards Diversification	PU
21/04/12	Pronova BioPharma AS : Pronova BioPharma ASA : Generic marketing authorisation in the UK	PU
29/03/12	Pronova BioPharma AS : Pronova BioPharma ASA: Pronova BioPharma has published its Annual Report 2011	PU
19/03/12	Pronova BioPharma AS : Presentation of Highlight Results from Phase 3 Trial of TAK-085 in Japan for the Treatment of Hyperlipidemia at the 76th Annual Scientific Meeting of the Japanese Circulation Society	PU
14/02/12	Pronova BioPharma AS : Pronova BioPharma ASA: Expanding the Pharmaceutical Business into Clinical Nutrition	PU
07/02/12	Pronova BioPharma AS : Pronova BioPharma ASA: Presentation of Q4 2011 results 14 February, 08:30 CET	PU
11/11/11	Pronova BioPharma AS : Pronova BioPharma ASA : Mandatory Notification of Trade	PU
11/11/11	Pronova BioPharma AS : Pronova BioPharma ASA: Strategic move into Omega-3 consumer market	PU
11/11/11	Pronova BioPharma AS : Pronova BioPharma launches Consumer Healthcare business	PU
04/11/11	Pronova BioPharma AS : Pronova BioPharma ASA : Presentation of Q3 2011 results 11 November, 08:30 AM CET	PU
20/10/11	Pronova BioPharma AS : Mandatory Notification of Trade	PU
19/09/11	Pronova BioPharma AS : PRC-4016 enters Phase I clinical trial for treatment of combined dyslipidemia	PU
15/09/11	Pronova BioPharma AS : Mandatory notification of trade	PU
12/08/11	Pronova BioPharma AS : Mandatory notification of trade	PU
12/08/11	Pronova BioPharma AS : New lipid-derived programme to enter clinical phase I trial	PU
04/08/11	Pronova BioPharma AS : Presentation of Q2 and first half year 2011 results 12 August, 08:30 AM CET	PU
22/09/10	Pronova BioPharma AS : Files Second Patent Infringement Action in Response to Par and Teva's Paragraph IV Notifications related to Lovaza(TM)	GL
21/09/10	Pronova BioPharma AS : Presentation at the UBS Global Life Sciences Conference 2010	GL